FDA clears blood test to help rule out Alzheimer’s disease in people showing symptoms

The US Food and Drug Administration has given clearance to another blood test to help assess Alzheimer’s disease and other ...
McKnight's Long-Term Care News

FDA: First-of-its-kind diagnostic test for Alzheimer’s gets green light

The first in vitro diagnostic test to detect brain plaques tied to Alzheimer’s disease can now be marketed to clinicians, the Food and Drug Administration announced this week. The Lumipulse G ...

Simple blood test gets green light by FDA to improve early detection of Alzheimer’s disease

The U.S. Food and Drug Administration has approved a second blood test to improve the detection of Alzheimer’s disease. The ...
WTHR

Roche Diagnostics gets OK from FDA to mass-produce at-home COVID-19 test

That’s how many rapid COVID-19 tests Indianapolis-based Roche Diagnostics plans to make, now that they have the green light from the Food and Drug Administration. The FDA granted emergency use ...
Business Wire

Anavasi Diagnostics Receives FDA Emergency Use Authorization for The AscencioDx COVID-19 Test and The AscencioDx Molecular Detector

REDMOND, Wash.--(BUSINESS WIRE)--Anavasi Diagnostics, an NIH/RADx funded medical technology company developing novel molecular diagnostic testing for the point-of-care (POC) market, announced the Food ...